Ildong Pharmaceutical Co., Ltd. (KRX: 249420)

Ildong Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Oct 10, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	410,606	502,483	764,721	799,187	449,542	379,499
Market Cap Growth	-14.09%	-34.29%	-4.31%	77.78%	18.46%	-18.14%
Enterprise Value	564,440	480,579	872,139	869,595	531,687	290,099
Last Close Price	14700.00	18160.00	28550.00	33600.00	18900.00	15952.38
PE Ratio	-	-6.18	-5.31	-8.02	-34.53	-28.23
PS Ratio	0.67	0.84	1.20	1.43	0.80	0.73
PB Ratio	2.51	2.80	3.75	4.79	1.77	1.50
P/FCF Ratio	-19.35	-10.09	-11.69	-30.75	89.66	12.95
P/OCF Ratio	-63.43	-13.72	-14.28	-70.31	23.21	9.17
EV/Sales Ratio	0.93	0.80	1.37	1.55	0.95	0.56
EV/EBITDA Ratio	78.35	-19.15	-19.77	-34.64	16.02	11.00
EV/EBIT Ratio	-26.68	-9.00	-11.84	-15.98	96.16	-188.09
EV/FCF Ratio	-30.08	-9.65	-13.33	-33.46	106.04	9.90
Debt / Equity Ratio	1.26	1.19	1.02	1.35	0.66	0.66
Debt / EBITDA Ratio	30.12	-	-	-	5.03	6.29
Debt / FCF Ratio	-11.56	-4.27	-3.18	-8.70	33.28	5.66
Asset Turnover	0.97	0.95	0.93	0.85	0.92	0.88
Inventory Turnover	3.80	4.23	4.44	3.97	4.07	4.72
Quick Ratio	0.42	0.45	0.44	0.59	0.74	0.74
Current Ratio	0.77	0.76	0.91	0.84	1.26	1.10
Return on Equity (ROE)	-30.55%	-42.25%	-76.68%	-47.91%	-5.13%	-5.08%
Return on Assets (ROA)	-1.92%	-5.27%	-6.75%	-5.18%	0.57%	-0.16%
Return on Capital (ROIC)	-3.08%	-8.31%	-11.44%	-8.35%	0.82%	-0.23%
Earnings Yield	-12.13%	-15.71%	-18.51%	-12.48%	-2.90%	-3.54%
FCF Yield	-4.57%	-9.91%	-8.55%	-3.25%	1.12%	7.72%
Buyback Yield / Dilution	-3.05%	-2.61%	-10.76%	0.00%	0.02%	0.01%
Total Shareholder Return	-3.05%	-2.61%	-10.76%	0.00%	0.02%	0.01%

Source: S&P Capital IQ. Standard template. Financial Sources.